Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
DRTSW ALPHA TAU MEDICAL LTD C/WTS 07/03/2027 (TO PUR COM)
0.4200.0000.00%
Trading Session
02/02 11:44 ET
High
0.429
Open
0.429
Turnover
235.00
Low
0.420
Pre Close
0.420
Volume
550.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 31,800 shares, an increase of 10.8% from
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Decreases By 24.1%
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 28,700 shares, a decrease of 24.1% from
Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 37,
Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023
JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
Alpha Tau to Present at Upcoming November Investor Conferences
JERUSALEM, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau", or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
Alpha Tau Director Gives up Board Seat to Take up Chief Commercial Officer Role
Alpha Tau Medical (NASDAQ:DRTS) appointed Peter Melnyk as Chief Commercial Officer (CCO). Melnyk resigned from Alpha's board to assume the full-time position as CCO, the Israeli cancer drug company sa
Alpha Tau Medical to Participate in Upcoming September Investor Conferences
JERUSALEM, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ:DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the Company will participate in person at three upcoming inve
Alpha Tau Medical Announces First Alpha DaRT Patients Treated In France As Part Of Alpha DaRT Multicenter Skin Cancer Trial
JERUSALEM, May 23, 2022 /PRNewswire/ -- Alpha Tau Medical (NASDAQ:DRTS) (NASDAQ:DRTSW), the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT™, announced today that the first patie
Alpha Tau Medical Shares Surge in Heavy Trading
02:16 PM EDT, 03/24/2022 (MT Newswires) -- Alpha Tau Medical (DRTS) shares were up about 25% Thursday afternoon, with more than 10.0 million shares changing hands against a daily average of about 425,
No More
Company Overview
More
Healthcare Capital Corp. operates as a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on August 18, 2020 and is headquartered in Wilmington, DE.
CEO： Mr. Uzi Sofer
Market： NASDAQ
Listing Date： 01/15/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet